Not all decisions are equally important. Neither are your information needs. There are times when you need information—plus real experience, real insight, and pragmatic solutions that will withstand the scrutiny of the most senior pharma and biotech executives. That’s when you need Healogix.
From early-stage development to brand rejuvenation, Healogix delivers pragmatic, commercially viable business strategies for bio-pharmaceutical companies. We apply unparalleled industry, therapeutic category and methodological knowledge to critical commercialization issues.
Pharmaceutical research, customer expectations, payer requirements, physician attitudes, sales rep needs are all moving targets. Healogix blends experienced consultation with leading-edge market research, proprietary technology and unparalleled insight.
Harris Kaplan, CEO, was instrumental in developing and launching more than 75 new Rx products, including blockbusters Lipitor, Viagra, Crestor, Rituxan, Nexium, Norvasc and Herceptin. He heads a seasoned team of consultants and researchers who have expertise in both the pharma and biotech industries.